J. Goldman & Co’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$152K Sell
33,756
-6,744
-17% -$27K ﹤0.01% 609
2025
Q4
$154K Sell
40,500
-163,224
-80% -$635K ﹤0.01% 522
2025
Q3
$658K Buy
+203,724
New +$764K 0.02% 363
2024
Q4
Sell
-19,705
Closed -$129K 559
2024
Q3
$129K Hold
19,705
﹤0.01% 425
2024
Q2
$143K Sell
19,705
-8,295
-30% -$63.5K ﹤0.01% 408
2024
Q1
$213K Sell
28,000
-28,042
-50% -$219K 0.01% 363
2023
Q4
$255K Buy
56,042
+2,042
+4% +$6.89K 0.01% 294
2023
Q3
$213K Hold
54,000
0.01% 316
2023
Q2
$169K Sell
54,000
-67,500
-56% -$275K 0.01% 332
2023
Q1
$550K Buy
+121,500
New +$635K 0.02% 260
2021
Q2
Sell
-11,441
Closed -$167K 457
2021
Q1
$167K Sell
11,441
-60,903
-84% -$1.11M 0.01% 406
2020
Q4
$1.55M Buy
+72,344
New +$1.45M 0.08% 215

Other funds holding LRMR